Inventor · disambiguated record
Jaap Goudsmit
Also filed as: GOUDSMIT JAAP
20 granted patents·21 pending applications·335 citations·filing 1993–2023
95Inventor score
Files withCRUCELL HOLLAND BV9BIOMERIEUX SA8JANSSEN PHARMACEUTICALS INC4JANSSEN VACCINES & PREVENTION BV4LEYDEN LABORATORIES B V2
Top patents by PatentIndex Score
41 records- 0195US7696330B2Binding molecules against SARS-coronavirus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Granted Apr 13, 2010·68 cites·11 claims
- 0294US7425437B2Vaccines against West Nile VirusCRUCELL HOLLAND BV·Filed 2005·Granted Sep 16, 2008·18 cites·17 claims
- 0393US8106170B2Compositions against SARS-coronavirus and uses thereofTER MEULEN JAN HENRIK·Filed 2005·Granted Jan 31, 2012·48 cites·11 claims
- 0492US11124552B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Sep 21, 2021·8 cites·14 claims
- 0590US6531313B1Invasive bacterial vectors for expressing alphavirus repliconsINT AIDS VACCINE INITIATIVE·Filed 2000·Granted Mar 11, 2003·27 cites·45 claims
- 0688US11591377B2Heterologous administration of tau vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·20 claims
- 0788US8101739B2Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vectorSULLIVAN NANCY·Filed 2005·Granted Jan 24, 2012·10 cites·8 claims
- 0887US10301379B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted May 28, 2019·7 cites·23 claims
- 0987US9012618B2Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structuresSULLIVAN NANCY·Filed 2012·Granted Apr 21, 2015·5 cites·8 claims
- 1083US11472869B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Oct 18, 2022·1 cites·18 claims
- 1181US10562963B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Feb 18, 2020·1 cites·3 claims
- 1281US8697352B2Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1GOUDSMIT JAAP·Filed 2005·Granted Apr 15, 2014·4 cites·6 claims
- 1381US5585250ADampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapiesUS HEALTH·Filed 1993·Granted Dec 17, 1996·42 cites·12 claims
- 1479US7238530B2Isolation and amplification of nucleic acid materialsBIOMERIEUX SA·Filed 2001·Granted Jul 3, 2007·15 cites·14 claims
- 1578US5853724ADampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapiesUS HEALTH·Filed 1996·Granted Dec 29, 1998·41 cites·14 claims
- 1673US9074262B2Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1BIOMERIEUX SA·Filed 2014·Granted Jul 7, 2015·4 cites·15 claims
- 1773US6881537B1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1BIOMERIEUX BV·Filed 1998·Granted Apr 19, 2005·33 cites·17 claims
- 1871US10400034B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted Sep 3, 2019·1 cites·11 claims
- 1970US11958889B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Apr 16, 2024·0 cites·24 claims
- 2069US2023257433A1Heterologous Administration of Tau VaccinesJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2168US2009017068A1Vaccines against West Nile VirusCRUCELL HOLLAND BV·Filed 2008·Application pending·0 cites
- 2266US2017137900A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1BIOMERIEUX SA·Filed 2016·Application pending·0 cites
- 2366US2017145524A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1BIOMERIEUX SA·Filed 2016·Application pending·0 cites
- 2464US2006223056A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1BIOMERIEUX SA·Filed 2006·Application pending·0 cites
- 2564US2006228699A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1BIOMERIEUX SA·Filed 2006·Application pending·0 cites
- 2664US2006223057A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1BIOMERIEUX SA·Filed 2006·Application pending·0 cites
- 2762US2015292043A1Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1BIOMERIEUX SA·Filed 2015·Application pending·0 cites
- 2861US2010172917A1Binding molecules against SARS-coronavirus and uses thereofCRUCELL HOLLAND BV·Filed 2009·Application pending·0 cites
- 2961US2009285879A1Malaria prime/boost vaccinesCRUCELL HOLLAND BV·Filed 2008·Application pending·0 cites
- 3053US2023151080A1Methods for identifying coronavirus cross-reacting antibodiesLEYDEN LABORATORIES B V·Filed 2021·Application pending·0 cites
- 3153US2008131461A1Malaria Prime/Boost VaccinesCRUCELL HOLLAND BV·Filed 2005·Application pending·0 cites
- 3253US2005019759A1Attenuated HIV strains and uses thereofFiled 2004·Application pending·0 cites
- 3353US2023285541A1Methods and compositions for increasing immunity against coronavirusesLEYDEN LABORATORIES B V·Filed 2021·Application pending·0 cites
- 3453US2006263802A1Antigenic peptides of rabies virus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Application pending·0 cites
- 3549US2003170211A1Invasive bacterial vectors for expressing alphavirus repliconsFiled 2003·Application pending·0 cites
- 3649US2012014994A1Malaria prime/boost vaccinesPAU MARIA-GRAZIA·Filed 2011·Application pending·0 cites
- 3749US2006154243A1Antigenic peptides of SARS coronavirus and uses thereofTER MEULEN JAN·Filed 2006·Application pending·0 cites
- 3846US2003008275A1Attenuated HIV strains and use thereofFiled 2001·Application pending·0 cites
- 3943US2007128217A1Antigenic peptides of SARS coronavirus and uses thereofCRUCELL HOLLAND BV·Filed 2006·Application pending·0 cites
- 4041US9701718B2Adenovirus serotype 26 and serotype 35 filovirus vaccinesSULLIVAN NANCY J·Filed 2011·Granted Jul 11, 2017·0 cites·15 claims
- 4141US2006110803A1Antigenic peptides of SARS coronavirus and uses thereofCRUCELL HOLLAND BV·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →